7-144397490-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001080413.3(NOBOX):​c.1826C>T​(p.Pro609Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000514 in 1,536,732 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P609P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0013 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00042 ( 4 hom. )

Consequence

NOBOX
NM_001080413.3 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 4.17

Publications

0 publications found
Variant links:
Genes affected
NOBOX (HGNC:22448): (NOBOX oogenesis homeobox) This homeobox gene encodes a transcription factor that is thought to play a role in oogenesis. In mice, it is essential for folliculogenesis and regulation of oocyte-specific genes. Defects in this gene result in premature ovarian failure type 5.[provided by RefSeq, May 2011]
NOBOX Gene-Disease associations (from GenCC):
  • premature ovarian failure 5
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010829002).
BP6
Variant 7-144397490-G-A is Benign according to our data. Variant chr7-144397490-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 791163.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Benign=1, Likely_benign=2}.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00135 (205/152328) while in subpopulation AFR AF = 0.00397 (165/41570). AF 95% confidence interval is 0.00347. There are 1 homozygotes in GnomAd4. There are 98 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 205 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NOBOXNM_001080413.3 linkc.1826C>T p.Pro609Leu missense_variant Exon 10 of 10 ENST00000467773.1 NP_001073882.3 O60393-1
NOBOXNM_001436401.1 linkc.1475C>T p.Pro492Leu missense_variant Exon 8 of 8 NP_001423330.1
NOBOXNM_001436402.1 linkc.923C>T p.Pro308Leu missense_variant Exon 7 of 7 NP_001423331.1
NOBOXXM_017011742.3 linkc.1730C>T p.Pro577Leu missense_variant Exon 10 of 10 XP_016867231.1 O60393-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NOBOXENST00000467773.1 linkc.1826C>T p.Pro609Leu missense_variant Exon 10 of 10 5 NM_001080413.3 ENSP00000419457.1 O60393-1
NOBOXENST00000483238.5 linkc.1730C>T p.Pro577Leu missense_variant Exon 10 of 10 5 ENSP00000419565.1 O60393-2
NOBOXENST00000645489.1 linkc.1475C>T p.Pro492Leu missense_variant Exon 8 of 8 ENSP00000496732.1 A0A2R8Y8C8
NOBOXENST00000643164.1 linkc.*21C>T downstream_gene_variant ENSP00000495343.1 A0A2R8Y683

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
205
AN:
152210
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00398
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000309
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000850
AC:
118
AN:
138742
AF XY:
0.000872
show subpopulations
Gnomad AFR exome
AF:
0.00403
Gnomad AMR exome
AF:
0.000448
Gnomad ASJ exome
AF:
0.000599
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000270
Gnomad OTH exome
AF:
0.00167
GnomAD4 exome
AF:
0.000423
AC:
585
AN:
1384404
Hom.:
4
Cov.:
31
AF XY:
0.000492
AC XY:
336
AN XY:
683064
show subpopulations
African (AFR)
AF:
0.00408
AC:
129
AN:
31580
American (AMR)
AF:
0.000421
AC:
15
AN:
35670
Ashkenazi Jewish (ASJ)
AF:
0.000676
AC:
17
AN:
25148
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35718
South Asian (SAS)
AF:
0.00221
AC:
175
AN:
79210
European-Finnish (FIN)
AF:
0.0000286
AC:
1
AN:
34988
Middle Eastern (MID)
AF:
0.00281
AC:
16
AN:
5694
European-Non Finnish (NFE)
AF:
0.000182
AC:
196
AN:
1078510
Other (OTH)
AF:
0.000622
AC:
36
AN:
57886
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
29
57
86
114
143
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00135
AC:
205
AN:
152328
Hom.:
1
Cov.:
32
AF XY:
0.00132
AC XY:
98
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.00397
AC:
165
AN:
41570
American (AMR)
AF:
0.000523
AC:
8
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000865
AC:
3
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4822
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000309
AC:
21
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
11
23
34
46
57
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
1
Bravo
AF:
0.00145
ESP6500AA
AF:
0.00361
AC:
5
ESP6500EA
AF:
0.000629
AC:
2
ExAC
AF:
0.00124
AC:
29
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Oct 24, 2017
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Apr 19, 2024
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Reported as one of many candidate variants in a 46,XX male patient with inguinal testes, micropenis and hypospadias (Knarston K. 2018 https://minerva-access.unimelb.edu.au/handle/11343/221695); variant maternally inherited; In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: Knarston2018[Thesis]) -

Inborn genetic diseases Uncertain:1
Apr 09, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1826C>T (p.P609L) alteration is located in exon 10 (coding exon 10) of the NOBOX gene. This alteration results from a C to T substitution at nucleotide position 1826, causing the proline (P) at amino acid position 609 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Premature ovarian failure 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.19
.;.;T
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.70
T;T;T
M_CAP
Uncertain
0.21
D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Uncertain
0.10
D
MutationAssessor
Benign
1.5
.;.;L
PhyloP100
4.2
PrimateAI
Benign
0.32
T
PROVEAN
Uncertain
-2.6
.;D;D
REVEL
Benign
0.26
Sift
Uncertain
0.0010
.;D;D
Sift4G
Uncertain
0.015
.;D;D
Vest4
0.23, 0.17
MVP
0.82
MPC
0.14
ClinPred
0.038
T
GERP RS
3.6
Varity_R
0.043
gMVP
0.13
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115882574; hg19: chr7-144094583; API